Vascular Biology |
From the Institute for Arteriosclerosis Research, Division of Cell Biology and Ultrastructure Research (G.P., S.R., C.K., J.R., H.R.), and the Departments of Cardiothoracic Surgery (M.C.D.) and Pathology (H.A.B.), Münster, Germany.
Correspondence to Gabriele Plenz, PhD, Institute for Arteriosclerosis Research, Division of Cell Biology and Ultrastructure Research, Domagkstr 3, D-48149 Münster, Germany. E-mail plenz{at}uni-muenster.de
AbstractThe expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) and type VIII collagen was studied in human arteries. GM-CSF and type VIII collagen were codistributed in all layers of the walls of nondiseased arteries and during early atherogenesis with up to type V lesions. The number of cells expressing both mRNAs increased during the development of advanced atherosclerotic lesions. Whereas type VIII collagen expression increased further in complicated lesions, GM-CSF was downregulated. During early atherogenesis smooth muscle cells (SMC) and endothelial cells were the principal GM-CSF and type VIII collagen mRNA-expressing cell types. In advanced lesions monocytes/macrophages also expressed the mRNAs. In complicated lesions the number of GM-CSF mRNA-expressing SMC was markedly reduced. In in vitro experiments transforming growth factor-ß1, platelet-derived growth factor, and GM-CSF, but not basic fibroblast growth factor, stimulated the expression of type VIII collagen mRNA by SMC. GM-CSF transiently stimulated type VIII collagen transcription. Thus GM-CSF is a prominent component of the regulatory network influencing collagen metabolism during atherogenesis. By modulating the synthesis of type VIII collagen in SMC, GM-CSF may influence the course of plaque development and may govern processes such as cell movement, plaque stability, and thrombus organization.
Key Words: extracellular matrix remodeling plaque development endothelial cells macrophages
This article has been cited by other articles:
![]() |
M. Ditiatkovski, B.-H. Toh, and A. Bobik GM-CSF Deficiency Reduces Macrophage PPAR-{gamma} Expression and Aggravates Atherosclerosis in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2337 - 2344. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Adiguzel, G. Hou, D. Mulholland, U. Hopfer, N. Fukai, B. Olsen, and M. Bendeck Migration and Growth Are Attenuated in Vascular Smooth Muscle Cells With Type VIII Collagen-Null Alleles Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 56 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Murata, A. Tanimoto, K.-Y. Wang, M. Tsutsui, Y. Sasaguri, F. De Corte, and H. Matsushita Granulocyte Macrophage-Colony Stimulating Factor Increases the Expression of Histamine and Histamine Receptors in Monocytes/Macrophages in Relation to Arteriosclerosis Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 430 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. PLENZ, H. ESCHERT, S. BEISSERT, V. ARPS, J. R. SINDERMANN, H. ROBENEK, and W. VOLKER Alterations in the vascular extracellular matrix of granulocyte macrophage colony-stimulating factor (GM-CSF) -deficient mice FASEB J, August 1, 2003; 17(11): 1451 - 1457. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |